Replies to post #140897 on Biotech Values

[p3analyze]

AMGN sneezes, EXEL catches a cold

[DewDiligence]

FDA expands Xgeva label to hypercalcemia of malignancy following treatment with a bisphosphonate:

http://finance.yahoo.com/news/fda-approves-amgens-xgeva-denosumab-140000804.html